BBA
ASPX

Baker Bros. Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Baker Bros. Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,000
Closed -$2.51M – 137
2015
Q1 		$2.51M Buy
+25,000
New +$1.67M 0.02% 98

Baker Bros. Advisors's ASPX Position: Q2 2015 in Review

Baker Bros. Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 25,000 shares — an estimated $2.51M sold.

Baker Bros. Advisors first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $2.51M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Baker Bros. Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Baker Bros. Advisors sold 25,000 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $2.51M.
  • Baker Bros. Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Baker Bros. Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.51M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Baker Bros. Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.